Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...

Breakfast is an ambulatory event of either a V8 juice (vegetable serving) or an Ensure high protein drink.

Let me tell you about my daily routine. My biological alarm clock has me consistently awake at around 2:00 am and again ...

DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

As eight-year-old Elizabeth Struhs lay dying from a diabetes-induced ketoacidosis, the medicine that could have saved her ...

On Monday, DexCom Inc (DXCM) stock saw a decline, ending the day at $87.53 which represents a decrease of $-1.22 or -1.37% from the prior close of $88.75. The stock opened at $88.58 and touched a low ...

Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.